EHC

Business Context and Reporting Period

This Form 10-K covers HealthSouth Corporation (now Encompass Health Corp) for the fiscal year ended December 31, 2006. The company is the largest provider of rehabilitative health care and ambulatory surgery services in the United States, operating 978 facilities with approximately 33,000 employees. The reporting period marks a strategic pivot to reposition the company as a "pure play" provider of post-acute care, specifically focusing on inpatient rehabilitation, while seeking to divest its surgery centers, outpatient, and diagnostic divisions. The year was characterized by the resolution of major legal and financial issues stemming from prior accounting fraud, including the completion of recapitalization transactions and the final court approval of securities litigation settlements.

Key Financial Metrics

Note: The 2006 Net Loss includes a $365.6 million loss on early extinguishment of debt and $38.8 million in government/class action settlement expenses. The 2005 Net Loss includes a $215.0 million charge for securities litigation settlements.

Material Changes vs. Prior Period

• Revenue Decline: Net operating revenues decreased 3.8% to $3.0 billion, primarily driven by volume declines in the inpatient segment due to the phase-in of the Medicare "75% Rule" and reduced volumes in surgery centers and outpatient divisions.
• Recapitalization: The company completed a series of recapitalization transactions in March 2006, replacing prior indebtedness with approximately $3 billion of new long-term debt. This resulted in a $365.6 million loss on early extinguishment of debt recorded in 2006.
• Settlements and Litigation: While the 2005 loss was heavily impacted by a $215 million securities litigation charge, 2006 saw a reduction in this liability by $31.2 million upon final court approval. However, 2006 included $38.8 million in new settlement and litigation expenses.
• Recoveries: The company recorded a $47.8 million recovery of amounts due from former CEO Richard M. Scrushy following a court judgment for restitution of incentive bonuses.
• Divestiture Progress: In January 2007 (subsequent to year-end), the company announced an agreement to sell its outpatient division for approximately $245 million, marking the first step in its strategic repositioning.

Guidance, Outlook, and Risks

• Strategic Repositioning: Management plans to divest surgery centers, outpatient, and diagnostic divisions to deleverage the company and focus on inpatient rehabilitation. Proceeds from these sales are intended to pay down debt.
• Regulatory Challenges: The company faces significant headwinds from the Medicare "75% Rule," which requires 75% of inpatient rehabilitation patients to have specific qualifying conditions. This has caused volume volatility and revenue declines. Management anticipates volume declines in Q4 2007 as facilities adjust to a 65% compliance threshold.
• Liquidity and Debt: The company remains highly leveraged with approximately $3.4 billion in long-term debt. It has significant cash obligations in 2007, including $86.7 million for the Medicare Program Settlement and $50.0 million for the SEC Settlement.
• Internal Controls: Management identified a material weakness in internal controls over financial reporting related to income taxes, specifically regarding the accurate determination of income taxes receivable/payable and deferred tax assets/liabilities.
• Outlook: Management expects 2007 operating results to reflect the transition period but remains optimistic about long-term positioning in the inpatient rehabilitation market, anticipating consolidation opportunities as competitors struggle with regulatory changes.

Key Facts for Investor Verification

• Debt Covenants: Verify compliance with the new Credit Agreement covenants, specifically the minimum interest coverage ratio (1.65:1) and maximum leverage ratio (7.50:1), given the high debt load and settlement payment obligations in 2007.
• Divestiture Execution: Monitor the closing of the outpatient division sale to Select Medical and the progress of strategic alternatives for the surgery centers and diagnostic divisions to ensure proceeds are available for debt reduction.
• Medicare Compliance: Assess the impact of the 75% Rule on inpatient volumes and the effectiveness of mitigation strategies (e.g., marketing to compliant cases) in stabilizing the core revenue stream.
• Internal Control Remediation: Track the remediation of the material weakness in income tax accounting controls to ensure future financial reporting reliability.
• Settlement Payments: Confirm the company's ability to meet the $136.7 million in remaining government settlement payments due in 2007 without breaching liquidity covenants.